SoftOx Solutions AS — Board/Management Information 2024

Aug 12, 2024

SoftOx Solution AS: Cancellation of employment contract for ECOB Geir Almås and ICEO Christian Harstad

SoftOx Solution AS: Cancellation of employment contract for ECOB Geir Almås and ICEO Christian Harstad

According to the announcement made on the 2nd of July 2024, a majority of the shareholders have confirmed interest in replacing today’s ECOB Geir Hermod Almås with Ulrik Spork. The new board is expected to replace today's ICEO Christian Harstad with Thomas Bjarnsholt. To facilitate this Geir Hermod Almås and Christian Harstad have agreed to step down from their positions by early September 2024.

ECOB Geir Almås has agreed to step down from his position after completing the ongoing Right Issue. While being ECOB Geir Almås has been on leave from his position as Chief Executive Officer of Business Development. He has also had a consultancy agreement regulating his role as ECOB. These contracts give him 12 months' salary after pay. Geir Almås has agreed to cancel all existing contracts with the company and has accepted a six-month salary paid as shares with a total amount of 58.326.042 shares. The amount is calculated based on a six-month salary and the theoretical ex-right price (TERP) of NOK 0,0226 per share.

ICEO Christian Harstad has accepted negotiated terms for the cancellation of his employment contract with SoftOx Solutions AS which originally would have entitled him to receive 12 months after payment. Christian Harstad has accepted to receive only 3 months where two months will be compensated in cash and one month will be compensated with shares. The number of shares is calculated by using implicit theoretical ex-right price after the ongoing right issue is closed (TERP) equal to NOK 0,0226 per share.

For further information, please contact: 

Ingrid Juven, CFO of SoftOx Solutions AS

e-mail: ir@soft-ox.com 

Phone: Ingrid Juven, CFO: (+47) 918 76 165 

About SoftOx Solutions AS:

SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian MedTech/biotech company based in Oslo with the aim of helping to combat major threats to human health, namely the emergence of antimicrobial resistance (AMR), biofilm infections in chronic wounds and the spread of viruses.

For more information on SoftOx, visit www.soft-ox.com